In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...